Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TACE”

560 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 560 results

Not applicableEnrolling By InvitationNCT07258199
What this trial is testing

TACE Treats Nodular Goiter

Who this might be right for
Nodular Goiter
Peking Union Medical College Hospital 30
Not applicableLooking for participantsNCT06643208
What this trial is testing

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital 37
Not applicableStudy completedNCT05291338
What this trial is testing

Pharmacogenetic Study in Hepatocellular Carcinoma Patients.

Who this might be right for
Hepatocellular Carcinoma
Rehab Werida 107
Testing effectiveness (Phase 2)UnknownNCT04066543
What this trial is testing

TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Carcinoma, Hepatocellular
Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04157140
What this trial is testing

Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Jinglong Chen 48
Testing effectiveness (Phase 2)Ended earlyNCT01480817
What this trial is testing

Sorafenib VS TACE in HCC Patients With Portal Vein Invasion

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 2
Not applicableWithdrawnNCT05592197
What this trial is testing

Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT

Who this might be right for
Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Not applicableStudy completedNCT04813861
What this trial is testing

Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation

Who this might be right for
Hepatocellular Carcinoma
Central Hospital, Nancy, France 57
Post-approval studies (Phase 4)UnknownNCT02557503
What this trial is testing

Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE

Who this might be right for
Advanced Adult Primary Liver Cancer
Zhu Xu 110
Testing effectiveness (Phase 2)Study completedNCT06232759
What this trial is testing

TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 56
Testing effectiveness (Phase 2)Looking for participantsNCT04522544
What this trial is testing

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectableHCC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 55
Not applicableNot Yet RecruitingNCT06423144
What this trial is testing

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 150
Testing effectiveness (Phase 2)UnknownNCT02727309
What this trial is testing

Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
Peking University Cancer Hospital & Institute 30
Not applicableLooking for participantsNCT06788353
What this trial is testing

Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma

Who this might be right for
Transarterial ChemoembolizationSystemic TherapyUnresectable Hepatocellular Carcinoma
Sun Yat-sen University 500
Not applicableStudy completedNCT00857805
What this trial is testing

Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Loma Linda University 76
Not applicableUnknownNCT04967495
What this trial is testing

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 171
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314372
What this trial is testing

FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC)Liver Cancer Adult
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 86
Not applicableUnknownNCT03326375
What this trial is testing

Comparison of SBRTand Repeat TACE for HCC

Who this might be right for
HepatoCellular Carcinoma
Gangneung Asan Hospital 80
Large-scale testing (Phase 3)Looking for participantsNCT04803994
What this trial is testing

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 434
Not applicableUnknownNCT03398122
What this trial is testing

Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 248
Load More Results